These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36656526)

  • 1. Refolding of Proteins Expressed as Inclusion Bodies in E. coli.
    Sharma R; Anupa A; Rathore AS
    Methods Mol Biol; 2023; 2617():201-208. PubMed ID: 36656526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Solubilization and Refolding Buffers.
    Roufarshbaf M; Akbari V
    Methods Mol Biol; 2023; 2617():155-164. PubMed ID: 36656522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accurate quantitation for in vitro refolding of single domain antibody fragments expressed as inclusion bodies by referring the concomitant expression of a soluble form in the periplasms of Escherichia coli.
    Noguchi T; Nishida Y; Takizawa K; Cui Y; Tsutsumi K; Hamada T; Nishi Y
    J Immunol Methods; 2017 Mar; 442():1-11. PubMed ID: 27939301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refolding techniques for recovering biologically active recombinant proteins from inclusion bodies.
    Yamaguchi H; Miyazaki M
    Biomolecules; 2014 Feb; 4(1):235-51. PubMed ID: 24970214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical characterization of in vitro refolding in the quality by design paradigm: Refolding of recombinant human granulocyte colony stimulating factor.
    Pathak M; Dixit S; Muthukumar S; Rathore AS
    J Pharm Biomed Anal; 2016 Jul; 126():124-31. PubMed ID: 27206104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Method for Inclusion Bodies Production via E. coli Host System: rGCSF as Model Biotherapeutic Protein.
    Rani AK; Naira VR; Rathore AS
    Methods Mol Biol; 2023; 2617():249-256. PubMed ID: 36656530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and purification of recombinant human granulocyte colony-stimulating factor in fed-batch culture of Escherichia coli.
    Kim CK; Choi JH; Lee SB; Lee SM; Oh JW
    Appl Biochem Biotechnol; 2014 Mar; 172(5):2425-35. PubMed ID: 24390866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient process development of recombinant human granulocyte colony-stimulating factor (rh-GCSF) production in Escherichia coli.
    Babaeipour V; Khanchezar S; Mofid MR; Pesaran Hagi Abbas M
    Iran Biomed J; 2015; 19(2):102-10. PubMed ID: 25864815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and purification of biologically active recombinant human paraoxonase 1 from inclusion bodies of Escherichia coli.
    Bajaj P; Tripathy RK; Aggarwal G; Pande AH
    Protein Expr Purif; 2015 Nov; 115():95-101. PubMed ID: 26003526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of scFv protein recovery from E. coli by in vitro refolding and mild solubilization process.
    Sarker A; Rathore AS; Gupta RD
    Microb Cell Fact; 2019 Jan; 18(1):5. PubMed ID: 30642336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solubilization and Refolding of Inclusion Body Proteins.
    Singhvi P; Panda AK
    Methods Mol Biol; 2022; 2406():371-387. PubMed ID: 35089569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unit Operation-Spanning Investigation of the Redox System.
    Ebner J; Humer D; Sedlmayr V
    Methods Mol Biol; 2023; 2617():165-176. PubMed ID: 36656523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Removal and monitoring of residual nucleic acids from core streptavidin inclusion bodies for increased refolding yield.
    Mohamad Alias NN; Beng Ong EB; Liew MWO
    Protein Expr Purif; 2025 Jan; 225():106591. PubMed ID: 39181482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of recombinant human G-CSF from non-classical inclusion bodies in Escherichia coli.
    Trinh NTM; Thuoc TL; Thao DTP
    Braz J Microbiol; 2021 Jun; 52(2):541-546. PubMed ID: 33483893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioprocessing of therapeutic proteins from the inclusion bodies of Escherichia coli.
    Panda AK
    Adv Biochem Eng Biotechnol; 2003; 85():43-93. PubMed ID: 12930093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleic acids in inclusion bodies obtained from E. coli cells expressing human interferon-gamma.
    Krachmarova E; Ivanov I; Nacheva G
    Microb Cell Fact; 2020 Jul; 19(1):139. PubMed ID: 32652996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression, Solubilization, Refolding and Final Purification of Recombinant Proteins as Expressed in the form of "Classical Inclusion Bodies" in
    Hashemzadeh MS; Mohammadi M; Ghaleh HEG; Sharti M; Choopani A; Panda AK
    Protein Pept Lett; 2021; 28(2):122-130. PubMed ID: 32729411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human growth hormone inclusion bodies present native-like secondary and tertiary structures which can be preserved by mild solubilization for refolding.
    Chura-Chambi RM; Farah CS; Morganti L
    Microb Cell Fact; 2022 Aug; 21(1):164. PubMed ID: 35978337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solubilization and refolding of bacterial inclusion body proteins.
    Singh SM; Panda AK
    J Biosci Bioeng; 2005 Apr; 99(4):303-10. PubMed ID: 16233795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MB109 as bioactive human bone morphogenetic protein-9 refolded and purified from E. coli inclusion bodies.
    Kuo MM; Nguyen PH; Jeon YH; Kim S; Yoon SM; Choe S
    Microb Cell Fact; 2014 Feb; 13(1):29. PubMed ID: 24559319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.